Caffeine
The world's most-used cognitive and athletic enhancer.
Evidence tier
Strong
Research weight
Citations
20 verified / 20
Classification
Nootropic
❝
What the evidence says. Multiple high-quality RCTs / meta-analyses with consistent effects.
What is Caffeine?
Caffeine is a nootropic used for alertness. NutriDex grades the human evidence as Strong. Caffeine antagonizes adenosine receptors, reducing perceived effort and fatigue. It is one of the most robustly proven ergogenic aids, improving endurance, strength, power, and reaction time across hundreds of trials. Cognitively it sharpens alertness and vigilance, particularly when sleep-deprived. Tolerance develops with regular use, and timing matters for sleep — its half-life is ~5 hours.
Purported Benefits
✓Alertness
✓Endurance & power
✓Reaction time
✓Fat oxidation
Evidence by outcome
The same supplement can be well-proven for one use and unproven for another — here is the human evidence graded outcome by outcome.
| Outcome | Evidence | Effect | Studies |
|---|---|---|---|
| Endurance & aerobic performanceMultiple meta-analyses of RCTs show ~3-6 mg/kg improves time-to-exhaustion and time-trial performance; effect not reliably modified by CYP1A2 genotype. | Strong | ↑ benefit · moderate | 4 |
| Muscle strength & powerUmbrella and meta-analyses confirm a consistent but small ergogenic effect on strength (SMD ~0.18) and power; statistically robust, practically modest. | Strong | ↑ benefit · small | 3 |
| Alertness & vigilance under sleep lossMeta-analysis and RCTs show acute caffeine restores cognitive, driving and vigilance performance after sleep deprivation, peaking 2-4 h post-dose. | Strong | ↑ benefit · moderate | 3 |
| Attention & reaction timeMeta-analysis and RCTs show dose-dependent gains in reaction time and accuracy in healthy adults, though accuracy plateaus and declines at higher doses. | Moderate | ↑ benefit · small | 3 |
| All-cause/diabetes mortality (coffee)Large dose-response cohort meta-analyses link ~3 cups/day coffee to ~13% lower all-cause mortality, but these are observational and concern coffee, not isolated caffeine. | Moderate | ↑ benefit · small | 3 |
| Sleep disruption (harm)Randomized case-crossover trial found caffeinated coffee cut nightly sleep by ~36 min and raised premature ventricular contractions; timing/half-life matters. | Moderate | ⚠ risk · small | 1 |
Dosing & Compounds
Typical Dose
3–6 mg/kg pre-exercise for ergogenic effect; ≤400 mg/day generally safe for adults.
Active Compounds
Safety & Cautions
Safe ≤400 mg/day for most adults. Excess causes anxiety, palpitations, insomnia. Pregnancy limit ~200 mg/day. Educational only — always check with your doctor or pharmacist before combining Caffeine with any medicine.
Key Studies ★ 20 studies
Meta-analysis
Taghizadeh Bilondi 2024 (umbrella meta-analysis)
✓ PubMed
Umbrella meta-analysis of 9 prior meta-analyses found caffeine significantly increases muscle strength (SMD 0.18, 95% CI 0.14-0.21) and muscle endurance (SMD 0.30, 95% CI 0.21-0.38).
Meta-analysis
Barreto 2024 (systematic review/meta-analysis)
✓ PubMed
Three-level meta-analysis of 13 studies (440 participants) found caffeine is ergogenic for exercise performance but the benefit was not meaningfully modified by CYP1A2 (AA/AC/CC) genotype.
Meta-analysis
Xue 2025 (network meta-analysis)
✓ Full text
Network meta-analysis of 48 studies (612 participants) found low-dose caffeine capsules (~3 mg/kg) most effective at reducing endurance time-trial completion time, ahead of higher doses and gum.
Meta-analysis
Caffeine muscular power 2025 (systematic review/meta-analysis)
✓ Full text
Meta-analysis of 12 studies (230 participants) found acute caffeine improves resistance-exercise movement velocity (SMD 0.42) and mean power output (SMD 0.21).
meta-analysis
Coffee & lung cancer 2024 (dose-response meta-analysis)
✓ PubMed
Dose-response meta-analysis of 14 prospective cohorts (~1,061,854 participants, 19,643 lung cancer cases) found higher coffee intake associated with higher lung cancer risk (highest vs lowest RR 1.28, 95% CI 1.12-1.47; +6% per cup/day), likely confounded by smoking.
Meta-analysis
McLellan 2025
✓ PubMed
Systematic review and meta-analysis found acute caffeine improves attention in healthy adults, enhancing both reaction time and accuracy, with higher doses continuing to improve reaction time while accuracy gains plateau and then decline.
Umbrella review
Grgic 2020 umbrella review
✓ PubMed
Consistent ergogenic effects across endurance, power, and strength.
Meta-analysis
Mojica 2022 (systematic review/meta-analysis)
✓ PubMed
Meta-analysis of 21 RCTs (254 runners) showed caffeine (3-9 mg/kg) improved running time to exhaustion by ~17% (g=0.392) and modestly reduced time-trial completion time (g=-0.101).
meta-analysis
Bazal/coffee-AF 2022 (updated dose-response meta-analysis)
✓ PubMed
Dose-response meta-analysis of 10 prospective studies (11 cohorts, 723,825 participants, 30,169 atrial fibrillation events) found each additional cup/day of coffee associated with a 2% lower AF risk (RR 0.98, 95% CI 0.97-1.00).
Meta-analysis
Irwin 2020 (sleep loss)
✓ PubMed
Systematic review and meta-analysis found acute caffeine consumption following sleep loss significantly improves cognitive, physical, occupational, and driving performance versus placebo.
Meta-analysis
Li 2019 (coffee/all-cause mortality dose-response meta-analysis)
✓ PubMed
Dose-response meta-analysis of 21 cohort studies (>10 million participants, 240,303 deaths) found a nonlinear inverse association: 3 cups/day was associated with ~13% lower all-cause mortality (RR 0.87; 95% CI 0.84-0.89), with similar inverse associations for both caffeinated and decaffeinated coffee.
Guideline
ISSN position 2021
✓ PubMed
3–6 mg/kg reliably enhances performance; effects vary by genotype.
randomized controlled trial
Marcus 2023 CRAVE trial (randomized case-crossover, NEJM)
✓ PubMed
Randomized 14-day case-crossover RCT in 100 healthy adults found caffeinated coffee did not significantly increase premature atrial contractions (rate ratio 1.09, 95% CI 0.98-1.20) but increased premature ventricular contractions (RR 1.51, 95% CI 1.18-1.94) and reduced nightly sleep by ~36 minutes.
RCT
Effects of different doses of caffeine 2024
✓ PubMed
Trial of different caffeine doses in healthy physically active adults reported dose-dependent effects on cognitive performance, supporting a dose-response relationship for attention and reaction time.
RCT
Modafinil vs caffeine aircrew RCT 2023
✓ Full text
Randomized controlled trial in air force crewmembers found 300 mg caffeine significantly decreased the impact of limited sleep deprivation on night-time vigilance versus placebo, with effects most notable 2-4 hours after administration.
Agency / regulator
EFSA Scientific Opinion on caffeine safety
✓ Source
EFSA concluded habitual single doses up to 200 mg and daily intakes up to 400 mg from all sources are not a safety concern for healthy adults (200 mg/day in pregnancy; 3 mg/kg for children/adolescents).
Agency / regulator
FDA Consumer Update on caffeine
✓ Source
FDA cites roughly 400 mg/day (about 4-5 cups of coffee) as an amount not generally associated with dangerous negative effects in healthy adults, while warning of toxicity risk from pure/highly concentrated caffeine.
Observational
Coffee/tea & diabetes mortality 2025 (meta-analysis)
✓ PubMed
Meta-analysis of prospective cohorts in people with diabetes found highest vs lowest coffee intake associated with lower all-cause mortality (HR 0.82, 95% CI 0.73-0.91) and CHD mortality.
prospective cohort study
Lu 2025 coffee & T2D incidence (3 US prospective cohorts)
✓ PubMed
Pooled analysis of three large US cohorts (NHS, NHS II, HPFS; 13,281 incident type 2 diabetes cases over 3.66 million person-years) found each additional cup of plain coffee associated with ~10% lower T2D risk, with the benefit attenuated by added sugar.
Review
McLellan 2016 review
✓ PubMed
Improves vigilance and cognition, especially under sleep loss.